Papers/PMID:33375477
Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.
Nutrients2020The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
Zn(2+) — increases all-cause mortality
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Increased whole blood Zn per 1 mg/L was significantly associated with a 32% higher HR for all-cause mortality, serum Cu per 0.1 mg/L with 18%, and Cu:Zn ratio per 0.1 arbitrary unit with 6%.”
Quoted verbatim from Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.. - Study
- cohort
- Population
- Newly diagnosed, treatment-naive lung cancer patients; endogenous whole blood zinc concentration (not an administered dose), univariate Cox analysis, median follow-up 43 months
Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.2020PMID:33375477Permalink